MUSK and myasthenia gravis: In a phase 2, randomized, double-blind, placebo-controlled study, 60 patients with generalized AChR- or MuSK Ab-associated MG were enrolled in 4 different active and 1 placebo treatment arms (ClinicalTrials.gov Identifier: NCT03772587).